Skip to main content
Fig. 1 | Experimental Hematology & Oncology

Fig. 1

From: Synergistic effect of HDAC inhibitor Chidamide with Cladribine on cell cycle arrest and apoptosis by targeting HDAC2/c-Myc/RCC1 axis in acute myeloid leukemia

Fig. 1

The inhibition effects of Chidamide (CHI) alone in AML cells. The cell proliferation assays in (A) U937 cells and (B) THP-1 cells were treated by CHI alone with gradient concentration for 24, 48, and 72 h. The statistic histogram and flow cytometry histogram of cell cycle effect in (C, E) U937 cells and (D, F) THP-1 cells that were treated by CHI alone with gradient concentration for 48 h. The statistic histogram and flow cytometry scatter plot of apoptosis effect in (G, I) U937 cells and (H, J) THP-1 cells that were treated by CHI alone with gradient concentration for 48 h. *p < 0.05, **p < 0.01, ***p < 0.001

Back to article page